COMP <GO>
XMTR vs PG // ALTMAN Z-SCORE & DEBT/EQUITY
Xometry Inc. (NASDAQ) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: XMTR 4
— PG 10
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: XMTR
LAST: $93.65 (-7.11%) • MKT CAP: $5.78B
balance-sheet
8.44
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
balance-sheet
5.59
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XMTR VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XMTR | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.10% | 51.20% | -12.10 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.80% | 25.40% | -33.20 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.42% | 3.77% | -4.19 | PG | /fcf-yield <GO> |
| Operating Margin | -6.60% | 24.30% | -30.90 | PG | /operating-margins <GO> |
| Net Profit Margin | -9.00% | 19.00% | -28.00 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 25.90% | 0.30% | +25.60 | XMTR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 8.44 | 5.59 | +2.85 | XMTR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.50% | +0.10 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.2 | 62.7 | -16.48 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.87 | +0.04 | XMTR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.0x | 21.7x | -1.70 | XMTR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.78B | $372.21B | -$366.43B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XMTR REV | PG REV | XMTR GROSS % | PG GROSS % | XMTR FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $686.6M | $84.28B | 39.1% | 51.2% | -$24.1M | $14.04B |
| FY 2024 | $545.5M | $84.04B | 39.5% | 51.4% | -$33.5M | $16.52B |
| FY 2023 | $463.4M | $82.01B | 44.0% | 44.0% | -$50.7M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XMTR // BETA 0.91
PG // BETA 0.87